2025-01-07 – Press Releases – www.prnewswire.com
Verismo will receive up to $4.05 million USD in investments from the Institute for Follicular Lymphoma Innovation (IFLI). The partnership with IFLI will accelerate the clinical development of SynKIR-310 in Follicular Lymphoma (FL) by leveraging IFLI’s expertise and network, expanding…